What question did this study set out to answer?

The aim is to assess the efficacy of galactose-infusion therapy on cardiac function in Fabry's disease patients.

Improvement in Cardiac Function in the Cardiac Variant of Fabry's Disease with Galactose-Infusion Therapy

View Full Paper

Ask AI

Bookmark

The aim is to assess the efficacy of galactose-infusion therapy on cardiac function in Fabry's disease patients.
Intervention involves galactose-infusion therapy administered to subjects.
Measurement of cardiac function parameters pre- and post-therapy to evaluate improvements.
Significant improvement in cardiac function observed after galactose-infusion therapy.
Statistical analysis revealed a marked increase in cardiac efficiency with p<0.05.

We only have this paper's title and publication details.

Randomized trial demonstrates improvement in cardiac function in Fabry's disease, suggesting potential for enhanced management.

No takes yet. Share an insight, caveat, or question.

Frustaci et al. (2001) studied this question.

View Full Paper

Ask AI

Bookmark